Compound, corresponding compositions, preparation and/or treatment methods

Compound, corresponding compositions, preparation and/or treatment methods

Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods prepar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dell'Orco, Philip C, Diederich, Ann Marie, Su, Qiaogong, Wood, Jeffery Lee
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Dell'Orco, Philip C
Diederich, Ann Marie
Su, Qiaogong
Wood, Jeffery Lee
description Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08158645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08158645</sourcerecordid><originalsourceid>FETCH-uspatents_grants_081586453</originalsourceid><addsrcrecordid>eNqNikEKwkAMAPfiQdQ_5AEVFa30XhTx7F2CG-tCN1mS9P9uwQd4GmaYZbj3kotMHBt4iSpZEY6Jh2q1W_IkbA0UpYKKswFy3ImCK6FnYodM_pFo67B442i0-XEV4Hp59LftZAW9jvYcFGfsu0PbnU_t8Y_lC0ykNto</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compound, corresponding compositions, preparation and/or treatment methods</title><source>USPTO Issued Patents</source><creator>Dell'Orco, Philip C ; Diederich, Ann Marie ; Su, Qiaogong ; Wood, Jeffery Lee</creator><creatorcontrib>Dell'Orco, Philip C ; Diederich, Ann Marie ; Su, Qiaogong ; Wood, Jeffery Lee ; GlaxoSmithKline LLC</creatorcontrib><description>Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8158645$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,778,800,883,64020</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8158645$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dell'Orco, Philip C</creatorcontrib><creatorcontrib>Diederich, Ann Marie</creatorcontrib><creatorcontrib>Su, Qiaogong</creatorcontrib><creatorcontrib>Wood, Jeffery Lee</creatorcontrib><creatorcontrib>GlaxoSmithKline LLC</creatorcontrib><title>Compound, corresponding compositions, preparation and/or treatment methods</title><description>Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNikEKwkAMAPfiQdQ_5AEVFa30XhTx7F2CG-tCN1mS9P9uwQd4GmaYZbj3kotMHBt4iSpZEY6Jh2q1W_IkbA0UpYKKswFy3ImCK6FnYodM_pFo67B442i0-XEV4Hp59LftZAW9jvYcFGfsu0PbnU_t8Y_lC0ykNto</recordid><startdate>20120417</startdate><enddate>20120417</enddate><creator>Dell'Orco, Philip C</creator><creator>Diederich, Ann Marie</creator><creator>Su, Qiaogong</creator><creator>Wood, Jeffery Lee</creator><scope>EFH</scope></search><sort><creationdate>20120417</creationdate><title>Compound, corresponding compositions, preparation and/or treatment methods</title><author>Dell'Orco, Philip C ; Diederich, Ann Marie ; Su, Qiaogong ; Wood, Jeffery Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_081586453</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dell'Orco, Philip C</creatorcontrib><creatorcontrib>Diederich, Ann Marie</creatorcontrib><creatorcontrib>Su, Qiaogong</creatorcontrib><creatorcontrib>Wood, Jeffery Lee</creatorcontrib><creatorcontrib>GlaxoSmithKline LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dell'Orco, Philip C</au><au>Diederich, Ann Marie</au><au>Su, Qiaogong</au><au>Wood, Jeffery Lee</au><aucorp>GlaxoSmithKline LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compound, corresponding compositions, preparation and/or treatment methods</title><date>2012-04-17</date><risdate>2012</risdate><abstract>Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08158645
source USPTO Issued Patents
title Compound, corresponding compositions, preparation and/or treatment methods
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A04%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dell'Orco,%20Philip%20C&rft.aucorp=GlaxoSmithKline%20LLC&rft.date=2012-04-17&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08158645%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true